Carlsmed Gains 510(k) for aprevo Cervical ACDF Interbody

Carlsmed aprevo Cervical ACDF Interbody

Carlsmed was granted FDA 510(k) clearance to market the aprevo Cervical ACDF Interbody System. U.S. commercial launch will occur next year.

FDA previously granted Breakthrough Device designation for aprevo technology for the treatment of patients with cervical spine disease. The company’s portfolio of aprevo interbody fusion devices for...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0